Department of Internal Medicine, Konkuk University School of Medicine, 4-12 Hwayang-dong, Gwangjin-gu, Seoul 143-729, Republic of Korea.
Dig Dis Sci. 2012 Aug;57(8):2184-94. doi: 10.1007/s10620-012-2245-x. Epub 2012 Jun 6.
The studies concerning the association between Helicobacter pylori status and colorectal adenoma, premalignant lesions of colorectal cancers, are not consistent.
This cross-sectional study investigated the association of colorectal adenoma with H. pylori infection in a consecutive series of 2,195 asymptomatic average-risk subjects who underwent screening colonoscopy and H. pylori testing. Multivariate analyses were adjusted for potential relevant confounders, including age, sex, smoking, alcohol consumption, family history of colorectal cancer, and regular use of aspirin. Furthermore, we performed a systematic literature review and meta-analysis of available studies, including the current study, to clarify whether H. pylori infection is associated with an increased risk of colorectal adenoma.
Among 2,195 eligible subjects, 1,253 subjects were H. pylori seropositive and 942 subjects were seronegative. In the H. pylori (+) group, the prevalence of colorectal adenoma and advanced adenoma was significantly higher than in the H. pylori (-) group (25.3 vs. 20.1 %, p = 0.004 and 6.1 vs. 2.9 %, p < 0.001, respectively). In our multivariate analysis, H. pylori seropositivity was an independent risk factor for overall colorectal adenoma (OR = 1.36, 95 % CI = 1.10-1.68) and advanced adenoma (OR = 2.21, 95 % CI = 1.41-3.48). The positive association was confined in cases with any proximal adenoma. In the meta-analysis, which included ten studies and 15,863 patients, the pooled OR for colorectal adenoma related to H. pylori infection was 1.58 (95 % CI = 1.32-1.88).
Our results from this cross-sectional study and current studies included in our meta-analysis indicated that H. pylori infection was associated with a modest increase in the risk for colorectal adenoma.
关于幽门螺杆菌(H. pylori)状态与结直肠腺瘤、结直肠癌前病变之间的关联,研究结果并不一致。
本横断面研究调查了连续 2195 例无症状低危人群的结直肠腺瘤与 H. pylori 感染之间的关系,这些人群接受了筛查性结肠镜检查和 H. pylori 检测。多变量分析调整了潜在的相关混杂因素,包括年龄、性别、吸烟、饮酒、结直肠癌家族史和阿司匹林的常规使用。此外,我们对包括本研究在内的现有研究进行了系统的文献回顾和荟萃分析,以明确 H. pylori 感染是否与结直肠腺瘤风险增加相关。
在 2195 例合格受试者中,1253 例为 H. pylori 血清阳性,942 例为血清阴性。在 H. pylori(+)组中,结直肠腺瘤和高级别腺瘤的患病率明显高于 H. pylori(-)组(25.3%比 20.1%,p=0.004;6.1%比 2.9%,p<0.001)。在多变量分析中,H. pylori 血清阳性是结直肠腺瘤(OR=1.36,95%CI=1.10-1.68)和高级别腺瘤(OR=2.21,95%CI=1.41-3.48)的独立危险因素。这种正相关仅局限于任何近端腺瘤的病例中。在荟萃分析中,纳入了 10 项研究和 15863 例患者,与 H. pylori 感染相关的结直肠腺瘤的汇总 OR 为 1.58(95%CI=1.32-1.88)。
本横断面研究结果和我们荟萃分析中纳入的现有研究结果表明,H. pylori 感染与结直肠腺瘤风险适度增加相关。